Skip to main content
SpringerLink
Log in

Regulations in the field of residue and doping analysis should ensure the risk of false positive declaration is well-defined

  • Discussion Forum
  • Published:
Accreditation and Quality Assurance Aims and scope Submit manuscript

Abstract

The purpose of this contribution is twofold, namely, to discuss the fundamental weaknesses of some decision criteria in the field of residue and doping analysis and to draw attention to a statistics-based solution that was proposed and thoroughly validated a decade ago, but nevertheless continues to be overlooked by practitioners.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Van Eenoo P, Delbeke FT (2004) Chromatographia 59:S39–S44. doi:10.1365/s10337-004-0198-8

    Article  Google Scholar 

  2. van der Voet H, de Boer WJ, de Ruig WG, van Rhijn JA (1998) J Chemometr 12:279–294. doi:10.1002/(SICI)1099-128X(199807/08)12:4<279::AID-CEM514>3.0.CO;2-7

    Article  Google Scholar 

  3. European Council (2002) Council Directive 2002/657/EC of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Off J Eu Communities L 221:8–36

    Google Scholar 

  4. Food and Drug Administration (2003) US Department of Health and Human Services, Center for Veterinary Medicine, Guidance for Industry. Mass spectrometry confirmation of the identity of animal drug residues, http://www.fda.gov/cvm/guidance/guide118.pdf

  5. Association of Official Racing Chemists (2002) AORC guidelines for the minimum criteria for identification by chromatography and mass spectrometry, MS Criteria Working group, Version 19 June 2002, Internal communication to AORC members

  6. International Olympic Committee (1998) Analytical criteria for reporting low concentrations of anabolic steroids. Internal communication to IOC accredited laboratories, Lausanne, Switzerland

    Google Scholar 

  7. World Anti-Doping Agency (2004) Identification criteria for qualitative assays incorporating chromatography and mass spectrometry, Version 1.2, http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf

  8. Hughes CG (2002) Confirmation and quantitation of ractopamine in equine urine, Equine Pharmacology Department, Gluck Equine Research Center, University of Kentucky

  9. Fraga CF (2003) J Chromatogr A 1019:31–42. doi:10.1016/S0021-9673(03)01329-3

    Article  CAS  Google Scholar 

  10. Mazzarino M, Orengia M, Botrè F (2007) Rapid Commun Mass Spectrom 21:4117–4124. doi:10.1002/rcm.3326

    Article  CAS  Google Scholar 

  11. de Zeeuw RA (2004) J Chromatogr B 811:3–12

    Google Scholar 

  12. de Boer WJ, van der Voet H, de Ruig WG, van Rhijn JA, Cooper KM, Kennedy DG, Patel RKP, Porter S, Reuvers T, Marcos V, Muñoz P, Bosch J, Rodríguez P, Grases JM (1999) Analyst (Lond) 124:109–114. doi:10.1039/a807051b

    Article  Google Scholar 

  13. Bethem R, Boison J, Gale J, Heller D, Lehotay S, Loo J, Musser S, Price P, Stein S (2003) J Am Soc Mass Spectrom 14:528–541. doi:10.1016/S1044-0305(03)00137-5

    Article  CAS  Google Scholar 

  14. De Bièvre P (1997) Accredit Qual Assur 2:269. doi:10.1007/s007690050147

    Article  Google Scholar 

Download references

Acknowledgments

Thanks should be expressed to H. van der Voet for his critical assessment of the manuscript and to P. Kootstra for drawing my attention to the work of de Zeeuw.

Author information

Authors and Affiliations

  1. Chemometry Consultancy, Goudenregenstraat 6, 6573 XN, Beek-Ubbergen, The Netherlands

    Nicolaas (Klaas) M. Faber

Authors
  1. Nicolaas (Klaas) M. Faber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nicolaas (Klaas) M. Faber.

Additional information

Papers published in this section do not necessarily reflect the opinion of the Editors, the Editorial Board, and the Publisher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faber, N.(.M. Regulations in the field of residue and doping analysis should ensure the risk of false positive declaration is well-defined. Accred Qual Assur 14, 111–115 (2009). https://doi.org/10.1007/s00769-008-0468-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00769-008-0468-5

Keywords

Search

Navigation